BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6815638)

  • 1. [Thyroliberin and its importance in thyroid diseases].
    Vakulenko AD
    Probl Endokrinol (Mosk); 1982; 28(5):82-7. PubMed ID: 6815638
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of synthetic thyroliberin (thyrotropin-releasing factor)].
    Starkova NT; Ktova GA; Aleksandrova GF; Mel'nichenko GA; Matveeva LS
    Probl Endokrinol (Mosk); 1978; 24(5):103-10. PubMed ID: 100777
    [No Abstract]   [Full Text] [Related]  

  • 3. Diseases of the thyroid gland.
    Ladenson PW
    Clin Endocrinol Metab; 1985 Feb; 14(1):145-73. PubMed ID: 2861924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum prolactin fluctuation caused by TRH tolerance test in thyroid disorders].
    Inoue K; Enomoto K; Irie M
    Horumon To Rinsho; 1974 Apr; 22(4):519-23. PubMed ID: 4214487
    [No Abstract]   [Full Text] [Related]  

  • 5. [Exploration of the hypothalamo-hypophyseal-thyroid axis in children].
    Chaussain JL; Binet E; Vassal J; Job JC
    Arch Fr Pediatr; 1974; 31(6):575-86. PubMed ID: 4216339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interrelation of thyroid hormones and prolactin].
    Gladkova AI
    Probl Endokrinol (Mosk); 1984; 30(3):79-89. PubMed ID: 6429661
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid function tests in thyroid and nonthyroid disease.
    Trainer TD; Howard PL
    Crit Rev Clin Lab Sci; 1983; 19(2):135-71. PubMed ID: 6426859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the test using TRH in the exploration of thyroid diseases].
    Demeester-Mirkine N; Bossuyt A; Brauman H; Corvilain J
    Nouv Presse Med; 1975 Apr; 4(15):1125-9. PubMed ID: 49040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prolactin level in thyroid diseases and its reaction to thyroliberin].
    Vakulenko AD; Niiazova ZhM; Simakova GM
    Probl Endokrinol (Mosk); 1981; 27(4):6-10. PubMed ID: 6794025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of oral TRH on the thyroid function, thyrotropin and prolactin secretion, in 9 normal subjects].
    Slama G; Luton JP; Canivet B; Strauch G; Jourde B; Meyniel M; Bricaire H
    Ann Endocrinol (Paris); 1974; 35(5):587-90. PubMed ID: 4219113
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH).
    Rabello MM; Snyder PJ; Utiger RD
    J Clin Endocrinol Metab; 1974 Sep; 39(3):571-8. PubMed ID: 4213076
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral administration of thyrotropin-releasing hormone (TRH) in the diagnosis of thyreopathies.
    Felt V; Nedvídková J
    Czech Med; 1978; 1(3):162-8. PubMed ID: 100297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of thyroid gland diagnostics].
    zur Mühlen A von ; Hesch RD; Köbberling J
    Dtsch Med Wochenschr; 1974 Jul; 99(28):1504-5. PubMed ID: 4137441
    [No Abstract]   [Full Text] [Related]  

  • 15. Sexual impotence: studies of the hypothalamic-pituitary-thyroid axis and the effect of oral thyrotropin-releasing factor.
    Benkert O; Horn K; Pickardt CR; Schmid D
    Arch Sex Behav; 1976 Jul; 5(4):269-74. PubMed ID: 182105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin and thyrotropin in thyroid diseases: lack of evidence for a physiological role of thyrotropin-releasing hormone in the regulation of prolactin secretion.
    L'Hermite M; Robyn C; Golstein J; Rothenbuchner G; Birk J; Loos U; Bonnyns M; Vanhaelst L
    Horm Metab Res; 1974 May; 6(3):190-5. PubMed ID: 4209662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities in the use of synthetic "thyrotropin releasing factor" (TRF) in the functional diagnosis of thyroid gland diseases].
    zur Mühlen A von ; Hesch RD; Emrich D; Köbberling J
    Verh Dtsch Ges Inn Med; 1971; 77():655-7. PubMed ID: 5005537
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentrations.
    Azizi F; Vagenakis AG; Portnay GI; Rapoport B; Ingbar SH; Braverman LE
    N Engl J Med; 1975 Feb; 292(6):273-7. PubMed ID: 803298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical thyroid disease: consensus or conundrum?
    Cooper DS
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):410-2. PubMed ID: 15049953
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
    Krysiak R; Gilowska M; Szkróbka W; Okopień B
    Pharmacol Rep; 2016 Apr; 68(2):490-4. PubMed ID: 26922558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.